Yahoo

SC’s 1st inmate to be executed in 13 years will die by lethal injection, attorney decides

Add Yahoo as a preferred source to see more of our stories on Google. Restraints are shown on the lethal injection table in the execution chamber at the Utah State Correctional Facility after the ...
The Greenville News

Questions, issues still to be resolved in years-long case against death penalty in SC

In an effort to resume executions in South Carolina after over a decade, the state Department of Corrections has notified the state Supreme Court that the agency now has the drugs to carry out lethal ...
Post and Courier

SC has lethal injection drug, but justices want more info before restarting executions

COLUMBIA — South Carolina's highest court apparently is not ready to allow the state to restart executions after more than 12 years until they hear more arguments about newly obtained lethal injection ...
Nasdaq

European Commission approves Roche’s Tecentriq SC, the EU's first PD-(L)1 cancer immunotherapy subcutaneous injection for multiple cancer types

Subcutaneous (SC) injection offers the potential for a faster, more convenient alternative to intravenous (IV) infusion and is preferred by cancer patients, nurses and physicians1-5 Tecentriq SC ...
The State

SC inmate will be executed by lethal injection. Here’s how the method will work

When South Carolina executes a man for the first time in more than a decade this Friday, the state will use the most common method of execution in the United States. Convicted murderer Freddie Owens ...
Business Wire

Genentech’s Subcutaneous Ocrevus One-Year Data Demonstrates Near-Complete Suppression of Clinical Relapses and Brain Lesions in Patients With Progressive and Relapsing Forms ...

– Results from the Phase III study showed that subcutaneous (SC) injection was consistent with IV infusion and demonstrated near-complete suppression of relapse activity (97%) and MRI lesions (97.2%) ...
The American Journal of Managed Care

Will Subcutaneous PD-1/PD-L1 Inhibitors Be a Game Changer?

With Bristol Myers Squibb (BMS) now rolling out the SC version of rival nivolumab (Opdivo Qvantig), the shift from 30-minute intravenous (IV) infusion to 5-minute SC injection could be one of the most ...
Nasdaq

Roche’s OCREVUS subcutaneous administration approved by European Commission, as first and only twice-a-year injection for relapsing and primary progressive multiple sclerosis

OCREVUS subcutaneous (SC) injection offers a new, 10-minute administration of OCREVUS with comparable efficacy and safety to intravenous infusion (IV) OCREVUS SC provides an additional treatment ...